KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Receivables - Other: 2018-2024

Historic Receivables - Other for Idexx Laboratories (IDXX) over the last 7 years, with Dec 2024 value amounting to $60.8 million.

  • Idexx Laboratories' Receivables - Other rose 17.16% to $72.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.0 million, marking a year-over-year increase of 17.16%. This contributed to the annual value of $60.8 million for FY2024, which is 10.23% up from last year.
  • Latest data reveals that Idexx Laboratories reported Receivables - Other of $60.8 million as of FY2024, which was up 10.23% from $55.1 million recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' Receivables - Other peaked at $60.8 million during FY2024, and registered a low of $23.8 million during FY2020.
  • Moreover, its 3-year median value for Receivables - Other was $55.1 million (2023), whereas its average is $52.6 million.
  • Data for Idexx Laboratories' Receivables - Other shows a peak YoY skyrocketed of 58.46% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Idexx Laboratories' Receivables - Other stood at $23.8 million in 2020, then spiked by 58.46% to $37.8 million in 2021, then rose by 10.81% to $41.9 million in 2022, then surged by 31.67% to $55.1 million in 2023, then grew by 10.23% to $60.8 million in 2024.